Table 3.
Prevalence of metabolic syndrome and its individual components according to RMM tertiles among the study population.
| RMM | ||||
|---|---|---|---|---|
| Tertile I (n = 78) | Tertile II (n = 75) | Tertile III (n = 81) | P for linear trend | |
| Central obesity, % (95% CI) |
62.8 (52.1-73.5) | 34.6 (23.8-45.4) | 13.6 (6.1-21.1) | <0.0001 |
| Elevated BP, % (95% CI) |
29.5 (19.4-39.6) | 17.3 (8.7-25.9) | 27.1 (17.4-36.8) | 0.75 |
| High TG, % (95% CI) |
35.9 (25.3-46.5) | 21.3 (12.0-30.6) | 21.0 (12.1-29.9) | 0.033 |
| Low HDL-C, % (95% CI) |
38.5 (27.7-49.3) | 20.0 (11.0-29.0) | 19.7 (11.0-28.4) | 0.008 |
| Glucose ≥ 5.6 mmol/L, % (95% CI) |
1.3 (0.2-6.9)* |
4.0 (1.4-11.1)* | 3.7 (1.27-10.3)* | 0.36 |
| Insulin resistance, % (95% CI) |
70.5 (60.4-80.6) | 52.0 (35.0-69.0) | 51.8 (40.9-62.7) | 0.023 |
| NAFLD, % (95% CI) |
55.2 (32.9-70.5) | 33.3 (22.6-44.0) | 33.3 (23.1-43.5) | 0.006 |
| Metabolic syndrome, % (95% CI) |
29.5 (19.3-39.7) | 12.0 (4.6-19.3) | 3.7 (1.3-10.3)* | <0.0001 |
RMM, relative muscle mass; CI, confidence interval; BP, blood pressure; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; NAFLD, nonalcoholic fatty liver disease.
*
For these percentages, the exact 95% CI was calculated using the Wilson method.